Skip to main content
. 2019 May 29;12:75–85. doi: 10.2147/PGPM.S203585

Figure 1.

Figure 1

Patient reality when taking a drug. It is shown the different elements analyzed and taken into account by the interpretation software g-Nomic: Primary (PP) or secondary (SP) pathways, personal background genetics – Extensive (EM), Intermediate (IM), Ultra (UM), and Poor (PM) Metabolizers, drug–drug interactions, lifestyle, nutritional supplements inhibitors and inducers, and other risks.